Skip to content
Home / Companies / BVS BVS
Bioventus Inc. (BVS) XNAS SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Net insider buying (90d)
Latest BVS Insider Trades
About Bioventus Inc. (BVS) Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Headquarters DURHAM, NC
Employees 950
Listed 2021
Exchange XNAS https://www.bioventus.com SEC filings for BVS on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Grant or award 10 257,308 Option exercise 20 660,654
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
BVS Insider Transactions (Form 4) 104 37 Form 4 filings on record, the earliest from Dec 23, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jun 2, 2026 JB John A. Bartholdson - Director Option exercise Class A Common Stock 32,282
Recent BVS Form 8-K Filings 5
BVS Insider Trading - FAQ
What is the latest insider trade for BVS? Bioventus Inc. (BVS) had 10 insider filings in the last 90 days, with the most recent on 2026-06-04. The full record for BVS runs to 37 Form 4 filings, the earliest from 2024-12-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BVS stock? No insider purchases of BVS were filed in the last 90 days.
How many insiders are selling BVS stock? No insider sales of BVS were filed in the last 90 days. 6 sales are on record for this company.
Where can I see BVS SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BVS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BVS insider buys? Create a free InsiderAlpha account and press Watch on this page to add BVS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BVS insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $945.34M
P/E ratio 18.00
Dividend yield -
Average volume 733.4K
52 week high $15.89
52 week low $6.26
Today's high $13.97
Today's low $13.73
Open $13.84
Volume 445.7K
Previous close $13.79
Shares outstanding 68.31M Market cap
$945.34M
950 employees
Most-Active BVS Insiders - Last 90 Days 10 Jun 2, 2026 MS Martin P. Sutter - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 2, 2026 MS Martin P. Sutter - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 3, 2026 MS Martin P. Sutter - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Jun 2, 2026 GN Guy P. Nohra - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 2, 2026 GN Guy P. Nohra - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 3, 2026 GN Guy P. Nohra - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Jun 2, 2026 GN Guido J. Neels - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 2, 2026 GN Guido J. Neels - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 3, 2026 GN Guido J. Neels - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Jun 2, 2026 ML Mary Kay Ladone - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 2, 2026 ML Mary Kay Ladone - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 3, 2026 ML Mary Kay Ladone - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Jun 2, 2026 WH William A. Hawkins - Director Option exercise Restricted Stock Units 39,789 $0.00 -
Jun 3, 2026 WH William A. Hawkins - Director Grant or award Restricted Stock Units 30,994 $0.00 -
Jun 2, 2026 PC Philip G. Cowdy - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 2, 2026 PC Philip G. Cowdy - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 3, 2026 PC Philip G. Cowdy - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Jun 2, 2026 PB Pat Beyer - Director Option exercise Class A Common Stock 32,282 $0.00 -
Jun 2, 2026 PB Pat Beyer - Director Option exercise Restricted Stock Units 32,282 $0.00 -
Jun 3, 2026 PB Pat Beyer - Director Grant or award Restricted Stock Units 25,146 $0.00 -
Apr 1, 2021 PC Philip G. Cowdy - Director Grant or award Restricted Stock Units 2,700 $0.00 -
Apr 10, 2026 KC Katrina J. Church - Officer Option exercise Class A Common Stock 4,300 $0.00 -
Apr 10, 2026 KC Katrina J. Church - Officer Tax withholding / forfeiture Class A Common Stock 1,868 $9.06 $17K
Apr 10, 2026 KC Katrina J. Church - Officer Option exercise Restricted Stock Units 4,300 $0.00 -
Apr 10, 2026 AD Anthony D'Adamio - Officer Option exercise Class A Common Stock 9,925 $0.00 -
Apr 10, 2026 AD Anthony D'Adamio - Officer Tax withholding / forfeiture Class A Common Stock 4,312 $9.06 $39K
Apr 10, 2026 AD Anthony D'Adamio - Officer Option exercise Restricted Stock Units 9,925 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Option exercise Class A Common Stock 3,455 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Tax withholding / forfeiture Class A Common Stock 1,501 $8.62 $13K
Mar 13, 2026 KC Katrina J. Church - Officer Option exercise Class A Common Stock 3,500 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Tax withholding / forfeiture Class A Common Stock 1,521 $8.62 $13K
Mar 14, 2025 KC Katrina J. Church - Officer Grant or award Restricted Stock Units 14,000 $0.00 -
Mar 14, 2025 KC Katrina J. Church - Officer Grant or award Stock Option (Right to Buy) 16,000 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Grant or award Restricted Stock Units 24,000 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Grant or award Stock Option (Right to Buy) 27,000 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Option exercise Restricted Stock Units 3,455 $0.00 -
Mar 13, 2026 KC Katrina J. Church - Officer Option exercise Restricted Stock Units 3,500 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Option exercise Class A Common Stock 8,886 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Tax withholding / forfeiture Class A Common Stock 3,861 $8.62 $33K
Mar 13, 2026 AD Anthony D'Adamio - Officer Option exercise Class A Common Stock 8,750 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Tax withholding / forfeiture Class A Common Stock 3,802 $8.62 $33K
Mar 14, 2025 AD Anthony D'Adamio - Officer Grant or award Restricted Stock Units 35,000 $0.00 -
Mar 14, 2025 AD Anthony D'Adamio - Officer Grant or award Stock Option (Right to Buy) 40,000 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Grant or award Restricted Stock Units 83,000 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Grant or award Stock Option (Right to Buy) 92,000 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Option exercise Restricted Stock Units 8,886 $0.00 -
Mar 13, 2026 AD Anthony D'Adamio - Officer Option exercise Restricted Stock Units 8,750 $0.00 -
Mar 13, 2026 RC Robert E. Claypoole - Officer Tax withholding / forfeiture Class A Common Stock 14,553 $8.62 $125K
Mar 14, 2025 RC Robert E. Claypoole - Officer Grant or award Stock Option (Right to Buy) 153,000 $0.00 -
Mar 13, 2026 RC Robert E. Claypoole - Officer Grant or award Stock Option (Right to Buy) 309,000 $0.00 -
Feb 15, 2026 KC Katrina J. Church - Officer Option exercise Class A Common Stock 4,375 $0.00 -
Feb 15, 2026 KC Katrina J. Church - Officer Tax withholding / forfeiture Class A Common Stock 2,133 $8.27 $18K
Feb 15, 2026 KC Katrina J. Church - Officer Option exercise Restricted Stock Units 4,375 $0.00 -
Feb 15, 2026 AD Anthony D'Adamio - Officer Option exercise Class A Common Stock 12,980 $0.00 -
Feb 15, 2026 AD Anthony D'Adamio - Officer Tax withholding / forfeiture Class A Common Stock 6,327 $8.27 $52K
Feb 15, 2026 AD Anthony D'Adamio - Officer Option exercise Restricted Stock Units 12,980 $0.00 -
Jun 2, 2025 WH William A. Hawkins - Director Option exercise Restricted Stock Units 26,493 $0.00 -
Jun 3, 2025 WH William A. Hawkins - Director Grant or award Restricted Stock Units 39,789 $0.00 -
Jun 2, 2025 MS Martin P. Sutter - Director Option exercise Class A Common Stock 26,493 $0.00 -
Jun 2, 2025 MS Martin P. Sutter - Director Option exercise Restricted Stock Units 26,493 $0.00 -
Jun 3, 2025 MS Martin P. Sutter - Director Grant or award Restricted Stock Units 32,282 $0.00 -
Jun 2, 2025 GN Guido J. Neels - Director Option exercise Class A Common Stock 26,493 $0.00 -
Jun 2, 2025 GN Guido J. Neels - Director Option exercise Restricted Stock Units 26,493 $0.00 -
Jun 3, 2025 GN Guido J. Neels - Director Grant or award Restricted Stock Units 32,282 $0.00 -
Jun 2, 2025 GN Guy P. Nohra - Director Option exercise Class A Common Stock 26,493 $0.00 -
Jun 2, 2025 GN Guy P. Nohra - Director Option exercise Restricted Stock Units 26,493 $0.00 -
Jun 3, 2025 GN Guy P. Nohra - Director Grant or award Restricted Stock Units 32,282 $0.00 -
Apr 11, 2025 KC Katrina J. Church - Officer Open-market sale Class A Common Stock 1,283 $7.57 $10K
$CARM
Carisma Therapeutics Inc.
$PRCT
PROCEPT BioRobotics Corp
